Results

Bliss Gvs Pharma Ltd. - Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2019

| Updated on August 01, 2019 Published on August 01, 2019

BLISS GVS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2019 ,inter alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2019.

Further, pursuant to SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, the trading window for dealing in shares of the Company was closed for all the Designated Persons and their immediate relatives of the Company from July 01, 2019 and shall remain closed till 48 hours after the announcement of the Financial Results i.e. up to Wednesday, August 14, 2019.

Kindly acknowledge and take on record the same.

Pdf Link: Bliss Gvs Pharma Ltd. - Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2019

Source : BSE - www.bseindia.com

Published on August 01, 2019
This article is closed for comments.
Please Email the Editor